ZTS
Drug Manufacturers - Specialty & Generic · Healthcare
Head of Investor Relations
Head of Investor Relations
Zoetis Inc. (ZTS)Equibles does not estimate personal net worth.
Get an email with a short summary when Zoetis Inc. publishes a filing, an earnings call transcript or a press release.
Get ZTS alertsSteve Frank is recorded as Head of Investor Relations at Zoetis Inc. (ZTS). Steve Frank has spoken on 25 earnings calls across 1 company, most recently for Zoetis Inc. on August 6, 2026. Zoetis Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Zoetis Inc. includes Juan Ramón Alaix (CEO), James (Jay) Saccaro (CFO), James Saccaro (CFO and COO) and 7 others.
“I am joined today by Kristen Peck, Chief Executive Officer, and Whitney Joseph, Chief Financial Officer. This morning, we issued a press release announcing our financial results.”
“I am joined today by Kristen Peck, Chief Executive Officer, and Whitney Joseph, Chief Financial Officer. This morning, we issued a press release announcing our first quarter 2026 financial results.”
“Good morning, everyone, and welcome to the Zoetis 2025 full year and fourth quarter earnings call. I am joined today by Kristen Peck, our Chief Executive Officer, and Whitney Joseph, our Chief Financial Officer.”
“I am joined today by Kristen Peck, our Chief Executive Officer, and Whitney Joseph, our Chief Financial Officer.”
“I am joined today by Kristen Peck, our Chief Executive Officer, and Whitney Joseph, our Chief Financial Officer.”
ZTS
Drug Manufacturers - Specialty & Generic · Healthcare
Head of Investor Relations